Vensica Medical Secures US FDA Clearance to Advance Needle-Free OAB Therapy to Phase II
Vensica Medical moves forward with clinical trials of its needle-free drug delivery platform aimed at improving access and patient comfort in overactive bladder treatment.
Overactive Bladder | 01/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy